Dose specification and quality assurance of radiation therapy oncology group protocol 95-17; a cooperative group study of iridium-192 breast implants as sole therapy.
about
Radiotherapy protocol deviations and clinical outcomes: a meta-analysis of cooperative group clinical trialsWhat we have learned: the impact of quality from a clinical trials perspectiveRedesigning radiotherapy quality assurance: opportunities to develop an efficient, evidence-based system to support clinical trials--report of the National Cancer Institute Work Group on Radiotherapy Quality AssuranceIMRT credentialing for prospective trials using institutional virtual phantoms: results of a joint European Organization for the Research and Treatment of Cancer and Radiological Physics Center project.Is pre-trial quality assurance necessary? Experiences of the CONVERT Phase III randomized trial for good performance status patients with limited-stage small-cell lung cancer.A Japanese prospective multi-institutional feasibility study on accelerated partial breast irradiation using interstitial brachytherapy: treatment planning and quality assurance.Challenges in credentialing institutions and participants in advanced technology multi-institutional clinical trialsLong-Term Cancer Outcomes From Study NRG Oncology/RTOG 9517: A Phase 2 Study of Accelerated Partial Breast Irradiation With Multicatheter Brachytherapy After Lumpectomy for Early-Stage Breast CancerQuality assurance for clinical trialsHigh dose rate radiation treatment of experimental intramuscular prostate carcinoma.Accelerated partial breast irradiation: potential roles following breast-conserving surgery.RTOG 95-17, a Phase II trial to evaluate brachytherapy as the sole method of radiation therapy for Stage I and II breast carcinoma--year-5 toxicity and cosmesis.
P2860
Q26828964-43384C9B-BCA6-4F19-AE82-9E91CD902391Q27008209-78BCB5E8-D506-4E60-ACD6-869BA30C6C80Q27026968-18178CBB-D79B-4212-9347-D77611F77C22Q33716254-3F07248C-EFBA-4AA7-A28F-B4A1E134C759Q33823034-B9AE729E-D301-4EA9-A028-0E43D8D9F6FEQ35710119-6A9BA7E2-181F-4444-9FFB-DC51BF253B00Q36693526-60E2601D-A646-4F82-B1AF-EB25FF2F5C93Q37383075-5B002DE0-CAD2-44BC-975F-DC4CE3A6A1FFQ37402633-DFA1C6DD-DAFC-442C-877E-C1E21136FEA6Q42947033-CEB99DF2-F637-4276-813A-12D9DB467402Q44109932-D9B30EA2-07AD-4062-A05F-5EFF13A9DA64Q44988623-D111A550-5A18-4B18-99FD-00435124891E
P2860
Dose specification and quality assurance of radiation therapy oncology group protocol 95-17; a cooperative group study of iridium-192 breast implants as sole therapy.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Dose specification and quality ...... east implants as sole therapy.
@ast
Dose specification and quality ...... east implants as sole therapy.
@en
type
label
Dose specification and quality ...... east implants as sole therapy.
@ast
Dose specification and quality ...... east implants as sole therapy.
@en
prefLabel
Dose specification and quality ...... east implants as sole therapy.
@ast
Dose specification and quality ...... east implants as sole therapy.
@en
P2093
P2860
P1476
Dose specification and quality ...... east implants as sole therapy.
@en
P2093
Douglas Arthur
Elizabeth O'Meara
Geoffrey S Ibbott
Irene Harris
Julia White
Rachel Rabinovitch
Ramesh C Tailor
Raymond M Wilenzick
Robert R Kuske
W F Hanson
P2860
P304
P356
10.1016/J.IJROBP.2007.08.011
P407
P577
2007-12-01T00:00:00Z